Correction to: A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats (Nature Communications, (2019), 10, 1, (329), 10.1038/s41467-018-08276-6)

Julio C.B. Ferreira, Juliane C. Campos, Nir Qvit, Xin Qi, Luiz H.M. Bozi, Luiz R.G. Bechara, Vanessa M. Lima, Bruno B. Queliconi, Marie Helene Disatnik, Paulo M.M. Dourado, Alicia J. Kowaltowski, Daria Mochly-Rosen

Research output: Contribution to journalComment/debate

Abstract

Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-018-08276-6, published online 18 January 2019 The original version of this Article contained errors in Fig. 1i, Fig. 3e, Supplementary Fig. 6, Supplementary Fig. 8, and Supplementary Fig. 1. The Tom20 western blot band in Fig. 1i was erroneously presented upside down. The correct version of Fig. 1 is: (Figure presented.) which replaces the previous incorrect version: (Figure presented.) The βIPKC western blot band in Fig. 1h was duplicated and erroneously labeled as Drp1 in Fig. 3e. The correct version of Fig. 3 is: (Figure presented.) which replaces the previous incorrect version: (Figure presented.) The same error occurred in the corresponding uncropped blots, where the βIPKC band in Supplementary Fig. 5a was duplicated and erroneously labeled as Drp1 in Supplementary Fig. 6. The correct version of Supplementary Fig. 6 is: (Figure presented.) which replaces the previous incorrect version: (Figure presented.) In Supplementary Fig. 8, the lanes corresponding to TOM70 have been erroneously shifted to the right and reproduced in the cropped version included in Supplementary Fig. 1. The correct version of Supplementary Fig. 8 is: (Figure presented.) which replaces the previous incorrect version: (Figure presented.) The correct version of Supplementary Fig. 1 is: (Figure presented.) which replaces the previous incorrect version: (Figure presented.) Additionally, the original version of this Article omitted the following competing interests: ‘J.C.B.F and D.M.-R. are co-inventors of patent on “Antagonists of mitofusin 1 and beta II PKC association for treating heart failure”, PCT/US2019/062854. The remaining authors declare no competing interests.’ These errors have been corrected in both the PDF and HTML versions of the Article. Finally, the original version of this Article did not include uncropped blots corresponding to Fig. 1h (RACK1), Fig. 1i (βIIPKC, TOM20 and ALDH2) and Fig. 2d (βIIPKC, MFN1 and IDH2). The HTML has been updated to include a corrected version of the Supplementary Information.

Original languageEnglish
Article number2889
JournalNature Communications
Volume15
Issue number1
DOIs
StatePublished - Dec 2024
Externally publishedYes

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

Fingerprint

Dive into the research topics of 'Correction to: A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats (Nature Communications, (2019), 10, 1, (329), 10.1038/s41467-018-08276-6)'. Together they form a unique fingerprint.

Cite this